aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Scribe Therapeutics, founded with the mission to revolutionize genetic medicine, focuses on engineering, delivering, and developing next-generation CRISPR molecules to address and repair genetic disorders. The company offers advanced CRISPR-based therapeutics designed for precision and efficacy, targeting the underlying causes of genetic diseases. Scribe's market focus is on providing innovative solutions in the biotech sector, particularly in genetic medicine.
Notable figures affiliated with Scribe Therapeutics include leading scientists and biotech experts who contribute to its cutting-edge research and development. The company has garnered significant investment from prominent venture capital firms, underscoring its potential and credibility in the biotech industry. Key achievements include pioneering novel viral and non-viral delivery technologies that enhance in vivo genetic editing. Scribe's impact lies in its potential to transform the treatment landscape for genetic disorders, offering hope for effective and lasting cures.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Crispr Therapeutics
Technology
Biotech, GenAI
Tags
Therapeutics
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Global
When was Scribe Therapeutics founded?
Scribe Therapeutics was founded in 2017.
Where is Scribe Therapeutics’s headquarters located?
Scribe Therapeutics’s headquarters is located in Alameda, CA, US.
How many employees does Scribe Therapeutics have?
Scribe Therapeutics has 121 employees as of Feb 5, 2024.
How much has Scribe Therapeutics raised to-date?
As of July 05, 2023, Scribe Therapeutics has raised a total of $120M (USD) since May 17, 2023.
Add Comparison
Total Raised to Date
$120M
USD
Last Update May 17, 2023
Total Employees Over Time
121
As of Feb 2024
Scribe Therapeutics Address
1150 Marina Village Pkwy
Alameda,
California
94501
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts